1. Home
  2. NXL vs MHUA Comparison

NXL vs MHUA Comparison

Compare NXL & MHUA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • MHUA
  • Stock Information
  • Founded
  • NXL 2010
  • MHUA 1990
  • Country
  • NXL United States
  • MHUA China
  • Employees
  • NXL N/A
  • MHUA N/A
  • Industry
  • NXL Medical Specialities
  • MHUA Medical Specialities
  • Sector
  • NXL Health Care
  • MHUA Health Care
  • Exchange
  • NXL Nasdaq
  • MHUA Nasdaq
  • Market Cap
  • NXL 21.0M
  • MHUA 19.6M
  • IPO Year
  • NXL 2022
  • MHUA 2022
  • Fundamental
  • Price
  • NXL $0.89
  • MHUA $0.41
  • Analyst Decision
  • NXL Strong Buy
  • MHUA
  • Analyst Count
  • NXL 1
  • MHUA 0
  • Target Price
  • NXL $5.00
  • MHUA N/A
  • AVG Volume (30 Days)
  • NXL 123.3K
  • MHUA 175.5K
  • Earning Date
  • NXL 08-06-2025
  • MHUA 09-19-2025
  • Dividend Yield
  • NXL N/A
  • MHUA N/A
  • EPS Growth
  • NXL N/A
  • MHUA N/A
  • EPS
  • NXL N/A
  • MHUA 0.40
  • Revenue
  • NXL $174,813.00
  • MHUA $96,909,642.00
  • Revenue This Year
  • NXL $79.59
  • MHUA N/A
  • Revenue Next Year
  • NXL $334.65
  • MHUA N/A
  • P/E Ratio
  • NXL N/A
  • MHUA $1.05
  • Revenue Growth
  • NXL 16.42
  • MHUA N/A
  • 52 Week Low
  • NXL $0.59
  • MHUA $0.25
  • 52 Week High
  • NXL $4.49
  • MHUA $1.26
  • Technical
  • Relative Strength Index (RSI)
  • NXL 33.31
  • MHUA 51.02
  • Support Level
  • NXL $0.86
  • MHUA $0.36
  • Resistance Level
  • NXL $1.10
  • MHUA $0.41
  • Average True Range (ATR)
  • NXL 0.09
  • MHUA 0.03
  • MACD
  • NXL -0.02
  • MHUA 0.00
  • Stochastic Oscillator
  • NXL 7.30
  • MHUA 62.50

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About MHUA Meihua International Medical Technologies Co. Ltd.

Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.

Share on Social Networks: